Showing 1 - 20 results of 223 for search 'O.L. Barbarash', query time: 0.03s Refine Results
  1. 1
    DURATION OF DUAL ANTIPLATELET THERAPY

    DURATION OF DUAL ANTIPLATELET THERAPY by O. L. Barbarash

    Published 2016-07-01
    Get full text
    Article
  2. 2
    Address to the readers

    Address to the readers by O. L Barbarash, A. S. Galyavich

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Modern ways to reduced mortality of myocardial infarction. What should be done?

    Modern ways to reduced mortality of myocardial infarction. What should be done? by O. L. Barbarash, T. B. Pecherina

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Training of a highly professional cardiologist in modern conditions: myth or reality? On the issue of the updated Federal State Educational Standard of Higher Education in the Cardiology

    Training of a highly professional cardiologist in modern conditions: myth or reality? On the issue of the updated Federal State Educational Standard of Higher Education in the Card... by O. L. Barbarash, T. Yu. Kuznetsova

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?

    Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? by M. V. Zykov, O. L. Barbarash

    Published 2021-09-01
    Get full text
    Article
  6. 6
    Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction

    Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction by M. V. Zykov, O. L. Barbarash

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Association between frailty syndrome and physical activity in patients with coronary artery disease and multivessel coronary artery disease

    Association between frailty syndrome and physical activity in patients with coronary artery disease and multivessel coronary artery disease by K. E. Krivoshapova, O. L. Barbarash

    Published 2023-10-01
    Get full text
    Article
  8. 8
    LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS

    LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS by O. L. Barbarash, V. V. Kashtalap

    Published 2017-05-01
    Get full text
    Article
  9. 9
    RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION

    RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION by E. V. Tavlueva, O. L. Barbarash

    Published 2015-10-01
    Get full text
    Article
  10. 10
    Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus

    Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus by O. L. Barbarash, V. V. Kashtalap

    Published 2020-06-01
    Get full text
    Article
  11. 11
    Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban

    Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban by O. L. Barbarash, V. V. Kashtalap

    Published 2020-11-01
    Get full text
    Article
  12. 12
    Myocardial infarction in young patients. Is everything so obvious?

    Myocardial infarction in young patients. Is everything so obvious? by M. V. Zykov, O. L. Barbarash

    Published 2024-03-01
    Get full text
    Article
  13. 13
    TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS

    TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS by O. L. Barbarash, V. V. Kashtalap

    Published 2016-02-01
    Get full text
    Article
  14. 14
    Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes

    Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes by A. M. Kochergina, O. L. Barbarash

    Published 2023-11-01
    Get full text
    Article
  15. 15
    Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice

    Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice by O. L. Barbarash, V. V. Kashtalap

    Published 2018-11-01
    Get full text
    Article
  16. 16
    Socioeconomic determinants of eating behavior

    Socioeconomic determinants of eating behavior by D. P. Tsygankova, O. L. Barbarash

    Published 2021-06-01
    Get full text
    Article
  17. 17
    EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS

    EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS by O. L. Barbarash, M. V. Zykov

    Published 2016-01-01
    Get full text
    Article
  18. 18
    PSYCHOSOCIAL FACTORS DETERMINING PROGNOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

    PSYCHOSOCIAL FACTORS DETERMINING PROGNOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION by N. B. Lebedeva, O. L. Barbarash

    Published 2003-08-01
    Get full text
    Article
  19. 19
    Neurodynamics in young and middle-aged patients with arterial hypertension

    Neurodynamics in young and middle-aged patients with arterial hypertension by S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash

    Published 2008-04-01
    Get full text
    Article
  20. 20
    Acute coronary syndrome in patients with prior coronary artery bypass grafting. Literature review

    Acute coronary syndrome in patients with prior coronary artery bypass grafting. Literature review by O. L. Barbarash, R. S. Tarasov, V. I. Ganyukov

    Published 2022-02-01
    Get full text
    Article

Search Tools: